Athira Pharma, Inc. is a late-stage biopharmaceutical company headquartered in Bothell, Washington, focusing on innovative therapies designed to restore neuronal health and combat neurodegeneration. The firm is advancing a pipeline of small molecule candidates aimed at addressing the underlying mechanisms of neurodegenerative diseases, particularly Alzheimer’s disease. With its commitment to tackling substantial unmet medical needs, Athira Pharma is positioned to make significant contributions to the field of neurology, enhancing the quality of life for patients suffering from these debilitating conditions.